Who knows Li Yan of Qilu Pharmaceutical?

Li Yan, female, graduated from Shandong University with an MBA, and is currently the president of Qilu Pharmaceutical Group. Deputies to the 13th National People's Congress, national model workers, national outstanding entrepreneurs, winners of labor medals for enriching the people and strengthening the province in Shandong Province, top ten outstanding engineers in Shandong Province, representatives to the 10th Party Congress in Shandong Province, and representatives to the 10th and 11th Party Congresses in Jinan. From June, 5438 to October, 2009, since he became the general manager of Qilu Pharmaceutical Group, the sales revenue of Qilu Pharmaceutical in 20 14 years exceeded 10 billion yuan, and it entered the top ten pharmaceutical enterprises in China for many years.

Chinese name Li Yan

Date of birth1Feb. 974

Chinese nationality

Professional entrepreneur

graduate school of shandong university

National model worker, representative of the 10th Party Congress in Shandong Province, outstanding entrepreneur in China, and representative of the 13th National People's Congress.

Personal experience

1July 1993, Li Yan entered Qilu pharmaceutical company.

From June 5438 to October 2009, he served as the general manager of Qilu Pharmaceutical Co., Ltd.

At the end of 20 17, he became the president of Qilu pharmaceutical group.

Product field

Li Yan built Qilu Pharmaceutical into a product pattern in many fields such as anti-tumor, anti-infection, cardiovascular and cerebrovascular diseases, psychiatry, neurology, ophthalmology and so on. Established Qilu Pharmaceutical Boston Innovation Center. Nearly 100 kinds of national new drugs have been successfully developed, and more than 270 kinds of products have been listed. A number of studies have won national and provincial scientific and technological progress awards, and Saizhen won the second prize of 20 12 National Scientific and Technological Progress Award, and was awarded the title of "generic drug with the most clinical substitution value".

science and technology

Non-sterile APIs (fermentation, chemical synthesis), sterile APIs and various preparations have passed the certification of drug regulatory agencies in the United States, the European Union, Australia, the United Kingdom, South Africa and other countries and regions.

Enterprise field

Now it has developed into a modern comprehensive large-scale pharmaceutical enterprise with eight production bases and nearly 10 thousand employees in China. Last year, its sales revenue reached 654.38+04.475 billion yuan. In 20 14, the company's sales revenue exceeded 10 billion yuan, making it the first "10 billion private enterprise" in Jinan. [4] The company has been ranked among the top ten pharmaceutical enterprises in China and the top 100 taxpayers in Shandong Province for many years. At the same time, Li Yan is also "20 14 China Pharmaceutical Economic Person of the Year".

personnel training

Established a pharmaceutical research and management team with enterprises as the main body, complete specialties and reasonable structure, with an international perspective of pharmaceutical research, taking into account domestic and foreign markets, and aiming at innovation and imitation. At present, there are more than 400 full-time researchers, including doctoral researcher 1 1 person and master 106 person. More than 80 experts and professors from medicinal chemistry, biotechnology, pharmacology and other disciplines at home and abroad serve as Qilu's strong technical backing.

She enthusiastically called on all staff of Qilu Pharmaceutical to devote themselves to social welfare undertakings and participate in activities such as poverty alleviation, disaster relief, aiding students and supporting the army. More than ten love funds and volunteer groups, such as Qi Ai, Orange Ribbon and Everyone Help, initiated by her, have been playing a continuous role in promoting the harmonious development of society.